Vanguard High Dividend Yield ETF Newsroom

Trump Planning on Executive Order to Further Cut Medicare Drug Prices - Report

Seeking Alpha16:51 ET

Costco Reports a 7% Increase in U.S. Comparable Sales Despite a Negative Calendar Effect

Seeking Alpha16:30 ET

Shares of Chip Stocks Are Trading Higher Following a Report Indicating President Trump Will Rescind Global Chip Curbs.

Benzinga15:48 ET

Gilead to Invest About $32B in U.S. Manufacturing Through 2030

Seeking Alpha15:14 ET

VistaShares Launches the OMAH ETF as Buffett Passes the Torch to Abel

Seeking Alpha13:54 ET

Trump Administration Set to Cut Thousands of Bank Regulators - Report

Seeking Alpha13:38 ET

S&P 500's Five Most Overbought and Oversold Stocks

Seeking Alpha12:16 ET

This Is What Whales Are Betting On JPMorgan Chase

BenzingaMay 7 11:00 ET

This House of Representative Just Bought Up To $915K In AbbVie Stock

BenzingaMay 7 11:00 ET

Pfizer, J&J, Genentech Drugs Subject of FDA Advisory Panel Meeting This Month

Seeking AlphaMay 7 10:32 ET

Apollo: Beyond Tariffs, U.S. Companies Are Deeply Tied to China's Consumer Market

Seeking AlphaMay 7 10:24 ET

Oppenheimer Maintains Outperform on Walmart, Raises Price Target to $110

BenzingaMay 7 10:04 ET · Ratings

Marvell Technology Sinks After Postponing Investor Day, Narrowing Revenue Forecast

Seeking AlphaMay 7 08:32 ET

"Exxon Mobil Plans To Invest $1.5B In A Deepwater Oil Field In Nigeria" -Bloomberg

BenzingaMay 7 07:42 ET

PepsiCo's Powerhouse Gatorade Brand Turns 60

Seeking AlphaMay 7 06:30 ET

Will Asia welcome the "oil price dividend"?

International oil prices have dropped by $12 per barrel since the beginning of 2025. Morgan Stanley believes that if this decline continues, the Crude Oil Product burden in Asia will decrease from the current 3.1% to 2.3%. For every $10 per barrel drop in oil prices, the overall current account balance in Asia is expected to improve GDP by 0.4 percentage points.

wallstreetcnMay 7 02:02 ET

Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.

① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.

cls.cnMay 6 20:41 ET

Home Depot May Face Weaker Comps In Q1 As Choppy Spring And Tariff Risks Weigh

BenzingaMay 6 16:25 ET

What's Driving the Market Sentiment Around JPMorgan Chase?

BenzingaMay 6 14:00 ET

Home Depot Analyst Ratings

BenzingaMay 6 13:53 ET · Ratings